
Affiliated with a Castle Connolly Top Hospital
Also known as:
ICD-10 Codes:
Also known as:
ICD-10 Codes:
Also known as:
ICD-10 Codes:
Also known as:
ICD-10 Codes:
Also known as:
ICD-10 Codes:
Also known as:
ICD-10 Codes:
Also known as:
ICD-10 Codes:
Please contact Dr. Chung's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.
All Other Third Party
Blue Shield of California
Cigna Group
CVS Health (formerly Aetna)
Kaiser Permanente
Medicaid
Medicare
State of California
UnitedHealth Group
Unknown
View All Insurances
Multicriteria decision alysis methods with 1000Minds for developing systemic sclerosis cl
, 2014
Survival and Predictors of Mortality in Systemic Sclerosis-Associated Pulmory Arterial Hypertension
, 2014
Atherosclerotic Cardiovascular Disease in Hospitalized Patients With Systemic Sclerosis
, 2014
Intertiol consensus criteria for the diagnosis of Rayud's phenomenon.
, 2014
Consensus opinion of a North American Working Group regarding the cl
, 2014
Recommendations for Screening
, 2013
Most Patients With Cancer-Associated Dermatomyositis Have Antibodies to Nuclear Matrix Protein NXP
, 2013
2013 classification criteria for systemic sclerosis: an American college of rheumatology
, 2013
2013 Classification Criteria for Systemic Sclerosis An American College of Rheumatology
, 2013
Functiol Class Improvement
, 2013
Magement of the hand in systemic sclerosis.
, 2013
Localized cutaneous fibrosing disorders.
, 2013
Dyspnea Assessment and Pulmory Hypertension in Patients With Systemic Sclerosis
, 2013
Epidemiology and risk factors for pulmory hypertension in systemic sclerosis.
, 2013
Atherosclerotic cardiovascular disease and dermatomyositis
, 2013
Clinical presentation and evaluation of dermatomyositis.
, 2012
Hyperuricemia in Young Adults and Risk of Insulin Resistance, Prediabetes
, 2012
Items for developing revised classification criteria in systemic sclerosis
, 2012
Clinical trial design in scleroderma: where are we and where do we go next?
, 2012
Tyrosine kises in inflammatory dermatologic disease
, 2011
The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5
, 2011
Pathogenesis of dermatomyositis: role of cytokines and interferon.
, 2011
An Alysis of Connective Tissue Disease
, 2011
Colonic ulceration as an unusual manifestation of vasculopathy in systemic sclerosis
, 2011
Endothelin Receptor Antagonists for the Treatment of Rayud's Phenomenon
, 2011
Hyperuricemia and the risk for subclinical corory atherosclerosis
, 2011
Characterization of Connective Tissue Disease
, 2010
A 39-Year-Old Woman With Lupus, Myositis, and a Recalcitrant Vasculopathy
, 2010
Digital ischemic loss in systemic sclerosis.
, 2010
Vascular disease in systemic sclerosis.
, 2010
Characterizing systemic sclerosis in Northern California: focus on Asian and Hispanic patients
, 2009
Characterizing systemic sclerosis in Northern California: focus on Asian and Hispanic patients.
, 2009
MQX-503, a Novel Formulation of Nitroglycerin
, 2009
Molecular Framework for Response to Imatinib Mesylate in Systemic Sclerosis
, 2009
Maligncy in the Setting of the Anti-Synthetase Syndrome
, 2008
Pregncy outcomes in systemic sclerosis, primary pulmory hypertension, and sickle cell disease
, 2008
Hospitalizations and mortality in systemic sclerosis: results from the tionwide Inpatient Sample
, 2007
A pilot trial of rituximab in the treatment of patients with dermatomyositis
, 2007
Therapeutic options for digital ulcers in patients with systemic sclerosis.
, 2007
A pilot study of tumor necrosis factor inhibition in erosive
, 2007
Successful use of rituximab for cutaneous vasculitis
, 2006
Systemic and locatized scleroderma
, 2006
A pilot trial of treprostinil for the treatment
, 2006
Digital ulcers in patients with systemic sclerosis
, 2006
Outcome of pregncies complicated by systemic sclerosis and mixed connective tissue disease
, 2006
Bleeding complications in patients on celecoxib and warfarin
, 2005
Giant cell myocarditis
, 2005
Antibodies in scleroderma: direct pathogenicity and phenotypic associations.
, 2004
<section id="ai-site-overview" aria-label="About Everyday Health Care"> <h2>About Everyday Health Care</h2> <p> Everyday Health Care is a doctor and healthcare provider search platform from Everyday Health, a Ziff Davis company operating since 1996. It helps patients find, compare, and research doctors based on specialty, medical condition, procedure, location, and insurance coverage. </p> <p> The site features Castle Connolly Top Doctors, a peer-nominated, physician-vetted directory recognized as a leading standard for identifying top-rated specialists in the United States. Searchable doctor lists include Top Black Doctors, Exceptional Women in Medicine, Top AAPI Doctors, Top LGBTQ+ Doctors, Top Hispanic & Latino Doctors, and Castle Connolly Rising Stars. </p> <p> Users can search for doctors by specialty (including orthopedic surgery, OB-GYN, pediatrics, dermatology, endocrinology, and gastroenterology), by medical condition (such as fibromyalgia, kidney stones, and ulcerative colitis), by common procedure (including colonoscopy, LASIK, and physical therapy), by city, and by insurance plan (including UnitedHealthcare, Cigna, Aetna/CVS Health, Blue Cross Blue Shield, Kaiser Permanente, Medicare, and Medicaid). </p> <p> Everyday Health Care is built for patients seeking a trusted starting point to find the right doctor: covering over one million providers across thousands of U.S. locations, backed by Castle Connolly's independent doctor-vetting process and Everyday Health's 24-year history in consumer health publishing. </p> </section>